Arcutis Biotherapeutics, Inc.
ARQT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001787306
In the last 90 days, Arcutis Biotherapeutics, Inc. insiders filed 0 open-market purchases and 12 sales; 272 institutions reported holding it in 13F filings for Q2 2026, worth $3.45B in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Arcutis Biotherapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 208
- +21 vs. Q3 2024
- Shares held
- 128.9M
- +268.8K (+0.2%) vs. Q3 2024
- Total value
- $1.79B
- +$596.5M (+49.8%) vs. Q3 2024
- New holders
- 49
- 60 more added
- Sold out
- 28
- 65 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARQT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 272 | $3.45B |
| Q1 2026 | 270 | $3.12B |
| Q4 2025 | 283 | $3.75B |
| Q3 2025 | 239 | $2.37B |
| Q2 2025 | 230 | $1.78B |
| Q1 2025 | 241 | $1.97B |
| Q4 2024 | 208 | $1.79B |
| Q3 2024 | 188 | $1.20B |
| Q2 2024 | 186 | $1.18B |
| Q1 2024 | 168 | $1.24B |
| Q4 2023 | 133 | $327.1M |
| Q3 2023 | 134 | $356.7M |
| Q2 2023 | 136 | $684.0M |
| Q1 2023 | 144 | $787.6M |
| Q4 2022 | 141 | $979.6M |
| Q3 2022 | 139 | $1.13B |
| Q2 2022 | 115 | $1.05B |
| Q1 2022 | 106 | $929.8M |
| Q4 2021 | 93 | $961.8M |
| Q3 2021 | 103 | $1.09B |
| Q2 2021 | 102 | $1.24B |
| Q1 2021 | 94 | $1.35B |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Arcutis Biotherapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| State Street Corp | 4,950,725 | $69.0M | 0.00% | −690,906−12.2% | Reduced |
| Vanguard Group Inc | 6,440,715 | $89.7M | 0.00% | −521,920−7.5% | Reduced |
| Polar Capital Holdings Plc | 7,377,381 | $102.8M | 0.58% | +493,009+7.2% | Added |
| Frazier Life Sciences Management, L.P. | 8,785,284 | $122.4M | 5.08% | 00.0% | Unchanged |
| BlackRock, Inc. | 9,148,558 | $127.4M | 0.00% | +119,002+1.3% | Added |
| Rubric Capital Management LP | 10,966,672 | $152.8M | 2.78% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 11,399,138 | $158.8M | 5.88% | +677,627+6.3% | Added |
| Jennison Associates LLC | 12,339,792 | $171.9M | 0.10% | +676,295+5.8% | Added |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −1,358,500−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −323,701−100.0% | Sold out |
| Two Seas Capital LP | 0 | $0 | 0.00% | −312,122−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −237,174−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −182,800−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −100,172−100.0% | Sold out |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −88,457−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −47,728−100.0% | Sold out |
| Hennion & Walsh Asset Management, Inc. | 0 | $0 | 0.00% | −43,968−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −35,147−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −34,076−100.0% | Sold out |
| Cerity Partners LLC | 0 | $0 | 0.00% | −21,102−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −20,432−100.0% | Sold out |
| Moore Capital Management, LP | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −17,774−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −16,817−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −14,938−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −12,714−100.0% | Sold out |
| Teza Capital Management LLC | 0 | $0 | 0.00% | −10,327−100.0% | Sold out |
| Great West Life Assurance Co | 0 | $0 | 0.00% | −8,233−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −6,680−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −728−100.0% | Sold out |
| SJS Investment Consulting Inc. | 0 | $0 | 0.00% | −185−100.0% | Sold out |
| Park Place Capital Corp | 0 | $0 | 0.00% | −183−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −111−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −110−100.0% | Sold out |
| Colonial Trust Advisors | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Byrne Asset Management LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| PEAK6 Investments LLC | – | – | – | – | Not filed |